Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matharu, M. S.
Right arrow Articles by Goadsby, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matharu, M. S.
Right arrow Articles by Goadsby, P. J.
Related Collections
Right arrow All Headache
Right arrow Migraine
Right arrow Brain trauma
Neurology 2001;56:273-275
© 2001 American Academy of Neurology
Brief Communications

Post-traumatic chronic paroxysmal hemicrania (CPH) with aura

Manjit S. Matharu, MRCP; and Peter J. Goadsby, MD, DSc

From the Headache Group, Institute of Neurology, and the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

Address correspondence and reprint requests to Professor Peter J. Goadsby, Institute of Neurology, Queen Square, London WC1N 3BG, UK; e-mail: peterg{at}brain.ion.ucl.ac.uk

The authors describe a patient who developed chronic paroxysmal hemicrania (CPH) in close temporal relationship to a head injury. The subsequent attacks of CPH were associated with a typical migrainous sensory and motor aura. Administration of indomethacin 75 mg daily resulted in isolated occurrence of autonomic and aura symptoms in the absence of pain symptoms. The patient became completely asymptomatic on indomethacin 100 mg daily. Migrainous aura may be seen with trigeminal-autonomic headaches and may represent the expression of an aura-susceptibility gene rather than typical migraine headache biology.




This article has been cited by other articles:


Home page
 BMJ Case ReportsHome page
A S Cohen and P J Goadsby
Paroxysmal hemicrania responding to topiramate
BMJ Case Reports, July 7, 2009; 2009(jul07_1): bcr0620092007 - bcr0620092007.
[Abstract] [Full Text]

Home page
 BrainHome page
E. Cittadini, M. S. Matharu, and P. J. Goadsby
Paroxysmal hemicrania: a prospective clinical study of 31 cases
Brain, April 1, 2008; 131(4): 1142 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A S Cohen and P J Goadsby
Paroxysmal hemicrania responding to topiramate
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 96 - 97.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. B. Lipton, M. E. Bigal, T. J. Steiner, S. D. Silberstein, and J. Olesen
Classification of primary headaches
Neurology, August 10, 2004; 63(3): 427 - 435.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Bahra, A. May, and P. J. Goadsby
Cluster headache: A prospective clinical study with diagnostic implications
Neurology, February 12, 2002; 58(3): 354 - 361.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.